Anti-tumor activity of mTOR inhibitor temsirolimus for relapsed mantle cell lymphoma: A phase II trial in the North Central Cancer Treatment Group.
暂无分享,去创建一个
S. Ansell | S. Dakhil | S. Kaufmann | S. Geyer | T. Witzig | P. Flynn | R. Morton | D. Inwards | H. Gross | Paul J. Kurtin | R. Luyun